search
Oncodaily
Trends
- 1Samra Turajlić Co-Chairs Early Cancer Session at EDXCONF26▼Samra Turajlić: A Pleasure to Co-Chair the Biology and Models of Early Cancer Session at EDXCONF26
Oncologist and researcher Samra Turajlić co-chaired the Biology and Models of Early Cancer session at EDXCONF26, describing the experience as a pleasure. The session formed part of the conference's programme on the biological foundations of early-stage cancer. The remarks were reported by Oncodaily, an outlet covering developments in oncology.
- 2Joshua Zeidner promoted to full professor at UNC Medicine▼Joshua Zeidner Celebrates Promotion to Full Professor of Medicine at UNC Department of Medicine
Joshua Zeidner has been promoted to full professor of medicine at the University of North Carolina Department of Medicine. The promotion, reported by Oncodaily, marks a career milestone for Zeidner, who is known for his work in oncology. Colleagues and observers in the medical community have been noting the announcement.
- 3Shikha Prakash highlights precision medicine push for tailored patient care▼Shikha Prakash Highlights Precision Medicine and the Goal of Getting the Right Care to Every Patient
Shikha Prakash is drawing attention to precision medicine, arguing that the central aim of modern healthcare should be delivering the right treatment to the right patient at the right time. Her remarks, reported by oncology-focused news outlet Oncodaily, underline how genetic profiling and targeted therapies are reshaping cancer care and moving treatment away from one-size-fits-all approaches toward personalised care for every patient.
- 4Luis Chia Named Senior Director at Revolution Medicines▼Luis Chia Appointed Senior Director of Global Commercial Development at Revolution Medicines
Luis Chia has been appointed Senior Director of Global Commercial Development at Revolution Medicines, the California-based oncology company developing targeted cancer therapies. The announcement was reported by Oncodaily. The move signals the company's continued build-out of its commercial team as it advances its pipeline of precision medicines toward broader market readiness.
- 5Penn Medicine shares career lessons from radiation oncology leader▼Navigating a Life in Medicine: Lessons From a Radiation Oncology Leader – Penn Medicine
Penn Medicine has published a profile in which a senior radiation oncology leader reflects on building a career in medicine. The piece recounts lessons on mentorship, resilience and leadership in oncology, and is being shared in medical news circles, including coverage by Oncodaily, as readers look for guidance on navigating long careers in healthcare.
- 6Samantha Whitman Named Head of Translational Medicine Portfolio Integration at Pfizer▼Samantha Whitman Appointed Head of Translational Medicine Portfolio Integration at Pfizer
Pfizer has appointed Samantha Whitman as Head of Translational Medicine Portfolio Integration. The move places her in charge of aligning the company's translational medicine work across its drug development portfolio, a role that supports how early research findings feed into clinical programmes. The appointment was reported by the oncology-focused news outlet Oncodaily.
- 7Al-Ola Abdallah Calls for National ICE-T Congress 2026 in Kansas City▼Al-Ola Abdallah: It’s Time for the National ICE-T Congress 2026 in Kansas City
Al-Ola Abdallah is calling for a National ICE-T Congress to be held in Kansas City in 2026. The announcement appears in an item carried by Oncodaily, but no further details have been published about the congress's purpose, organisers, programme or expected participants. It is not yet clear who is backing the initiative or whether the city has confirmed any plans to host it.
- 8Karin Shanahan Highlights Purpose of Global Patient Week▼Karin Shanahan: Global Patient Week Exists to Tangibly Connect Us to the Patient Waiting for a Medicine
Karin Shanahan says Global Patient Week exists to tangibly connect the pharmaceutical industry to the patient waiting for a medicine. Speaking in the context of oncology care, she framed the initiative as a reminder that drug development ultimately serves individuals awaiting treatment. The remarks were published by oncology news outlet Oncodaily.
- 9Pfizer Offers Up to $250,000 for Prostate Cancer Medical Education Grants●Pfizer Independent Medical Education Grant: Up to $250,000 for New Mechanisms in Metastatic Castration-Resistant Prostate Cancer
Pfizer is funding an independent medical education grant of up to $250,000 focused on new mechanisms in metastatic castration-resistant prostate cancer. The programme, reported by Oncodaily, is aimed at supporting education for healthcare professionals on emerging approaches in this advanced stage of the disease. The grant falls under Pfizer's independent medical education funding, which supports unbranded, non-promotional learning initiatives.
- 10Revolution Medicines Explores Unexpected Turns in Cancer Science●What Happens When Science Leads Us in an Unexpected Direction? - Revolution Medicines
Revolution Medicines, a US oncology company, has published a piece asking what happens when scientific research leads in an unexpected direction. The item, picked up by cancer news outlet Oncodaily, frames the company's work on targeted cancer therapies as a story of following surprising data rather than a fixed plan. No specific finding or trial result is given.
- 11Sylvester Cancer Center Asks Who Is Shaping AI in Clinical Trials▼Are You Helping Shape How AI Is Implemented in Clinical Trial Operations? - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center is raising the question of who is helping determine how artificial intelligence is implemented in clinical trial operations. The item, highlighted by Oncodaily, points to an ongoing discussion in the oncology research community about the role clinicians, coordinators and sponsors play in adopting AI tools for running trials.
- 12Karolina Bryl Highlights Teamwork at MSK Integrative Medicine Service▼Karolina Bryl։ Proud to be Part of Our Collaborative MSK Integrative Medicine and Wellness Service Team
Karolina Bryl, a clinician at Memorial Sloan Kettering Cancer Center, expressed pride in being part of the institution's collaborative Integrative Medicine and Wellness Service team. Her remarks spotlight the center's team-based approach to combining supportive care, wellness, and integrative therapies for cancer patients. The statement was published by oncology-focused outlet Oncodaily.
- 13AI-driven integrative medicine in focus at KSIO 2026 symposium●AI-Driven Integrative Medical Paradigms at the KSIO 2026 Autumn International Symposium - SIO
The KSIO 2026 Autumn International Symposium is putting AI-driven integrative medical paradigms on its agenda, combining artificial intelligence with integrative oncology approaches. Coverage from Oncodaily highlights the event as a venue where clinicians and researchers discuss how AI tools can be woven into holistic cancer care, signalling growing medical interest in blending data-driven technology with whole-patient treatment models.